A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
Dean M. Wingerchuk(WinnMed), Moses Rodriguez(Mayo Clinic), Claudia F. Lucchinetti(Mayo Clinic in Arizona), Eduardo E. Benarroch(Mayo Clinic in Arizona), John H. Noseworthy(Mayo Clinic), Breffni Keegan(Mayo Clinic), Peter C. O’Brien(University Hospital Crosshouse), Brian G. Weinshenker(Mayo Clinic in Arizona)
Cited by 120
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k